Annual financial statement
Page 1
AnteoTech Ltd and its controlled entities Appendix 4E Preliminary final report 1. Company details Name of entity: AnteoTech Ltd ABN: 75 070 028 625 Reporting period: For the year ended 30 June 2026 Previous period: For the year ended 30 June 2025 2. Unaudited results for announcement to the market % $ Revenues from ordinary activities down 52% to 467,589 Interest and other income from ordinary activities up 7% to 2,661,555 Total revenue and other income from ordinary activities down 10% to 3,129,144 Loss from ordinary activities after tax attributable to the owners of AnteoTech Ltd down 27% to (4,928,074) Loss for the year attributable to the owners of AnteoTech Ltd down 27% to (4,928,074) The following unaudited information of AnteoTech Ltd for the year ended 30 June 2026 is attached: ● Consolidated Statement of Profit or Loss and Other Comprehensive Income ● Consolidated Statement of Financial Position ● Consolidated Statement of Changes in Equity ● Consolidated Statement of Cash Flows ● Notes to the Consolidated Financial Statements Dividends There were no dividends paid, recommended or declared during the current financial period. Comments The loss for the Group after providing for income tax amounted to $4,928,074 (30 June 2025: $6,759,135). For the year ended 30 June 2026 the Group generated revenues from ordinary activities of $467,589 (2025: $968,878). Revenues comprised of both product sales and contract services in Life Sciences as well as the revenues from Advanced Battery Technologies. The Company continued to receive recurring Life Sciences revenue under its five- year take- or-pay supply agreement with the Serum Institute of India (SII). The Company shipped $134,138 of AnteoBind TM to SII in July 2026. As the shipment was delivered post June 2026, this will be recorded as income in the following financial year. Revenues and other income from ordinary activities for the year totalled $3,129,144 (2025: $3,458,728) and included the Research and Development tax concession claim for Financial Year 2026 of $2,588,632 (2025: $2,385,553). Total expenses, excluding non- cash items such as depreciation and amortisation, and share- based payments were $6,410,307, a decrease of $2,040,807 year -on-year. The reduced expenses were primarily from lower salary and wages costs, professional services, D irector fees, and research expenses. This aligns with the ASX announcement titled “Strategic Review Outcomes”, released on 10 June 2025. During the year, the Company significantly strengthened its balance sheet through the exercise of all its listed ADOO options (exercise price 3.5 cents (A$0.035)), which raised $10,032,004 (before costs) following the Company entering into an underwriting agreement with MST Financial Services Pty Ltd. Cash on hand at the end of the period was $5,700,745 (2025: $2,340,306), plus the Company holds a $5,500,000 6-month Term Deposit maturing on 18 December 2026.
Page 2
AnteoTech Ltd and its controlled entities Appendix 4E Preliminary final report The Company received additional funding in January and February 2026 through a $3,808,350 Share Placement. The shares issued under the Placement were priced at 1.55 cents per share with an attaching option. In October 2024, AnteoTech entered into a funding agreement with The Australian Renewable Energy Agency (ARENA) of up to $4,000,000. The date for satisfying the first milestone for the funding agreement has been extended until November 2026. During the financial year, the Company withdrew from its funding agreement with the Queensland Critical Minerals and Battery Technology Fund. 3. Net tangible assets Reporting period Previous period Cents Cents Net tangible assets per ordinary security 0.36 0.12 4. Control gained over entities Not applicable. 5. Loss of control over entities Not applicable. 6. Dividends Current period There were no dividends paid, recommended or declared during the current financial period. Previous period There were no dividends paid, recommended or declared during the previous financial period. 7. Dividend reinvestment plans Not applicable. 8. Details of associates and joint venture entities Not applicable. 9. Foreign entities Details of origin of accounting standards used in compiling the report: Not applicable.
Page 3
AnteoTech Ltd and its controlled entities Appendix 4E Preliminary final report 10. Audit qualification or review Details of audit/review dispute or qualification (if any): The unaudited preliminary information is attached hereafter. The Company currently expect s to lodge audited financial statements for the year ended 30 June 2026 by 30 September 2026. 11. Attachments Details of attachments (if any): The unaudited Appendix 4E - Preliminary Final Report of AnteoTech Ltd for the year ended 30 June 2026 is attached. 12. Signed Signed ___________________________ Date: 31 August 2026 Ms Merrill Gray Managing Director and Chief Executive Officer Eight Mile Plains
Page 4
AnteoTech Ltd and its controlled entities Corporate directory 30 June 2026 1 Directors Ms Glenda McLoughlin, Chair Dr Geoffrey Cumming Ms Merrill Gray Company secretary Mr Scott Waddell Registered office and principal place business 4/26 Brandl Street Eight Mile Plains QLD 4113 Share register MUFG Corporate Markets Level 21, 10 Eagle Street Brisbane, QLD 4000 Auditor BDO Audit Pty Ltd Level 18, 360 Queen Street Brisbane, QLD 4000 Legal advisors Sparke Helmore Lawyers Level 23, 240 Queen Street Brisbane QLD 4000 Bankers Australia and New Zealand Banking Group Limited 1/3215 Logan Road, Underwood QLD 4119 Stock exchange listing AnteoTech Ltd shares are listed on the Australian Securities Exchange (ASX code: ADO) Website www.anteotech.com Corporate Governance Statement The Directors and management are committed to conducting the business of AnteoTech Ltd in an ethical manner and in accordance with the highest standards of corporate governance. AnteoTech Ltd has adopted and substantially complied with the ASX Corporate Governance Principles and Recommendations (Fourth Edition) (‘Recommendations’) to the extent appropriate to the size and nature of its operations. The Corporate Governance Statement and Policy, which sets out the corporate governance practices that were in operation during the financial year and identifies and explains any Recommendations that have not been followed, was approved by the Board of Directors at the same time as the Annual Report and can be found on the AnteoTech website at https://www.anteotech.com/corporate-governance-company-policy/
Page 5
AnteoTech Ltd and its controlled entities Consolidated statement of profit or loss and other comprehensive income For the year ended 30 June 2026 Consolidated Note 2026 2025 $ $ The above consolidated statement of profit or loss and other comprehensive income should be read in conjunction with the accompanying notes 2 Revenue from contracts with customers 5 467,589 968,878 Other income 6 2,598,354 2,431,020 Interest revenue 63,201 58,830 Total revenue and other income 3,129,144 3,458,728 Expenses Administration expenses 7 (2,555,444) (3,849,634) Depreciation and amortisation expense 7 (1,124,807) (1,123,382) Selling and distribution expenses (696,606) (640,497) Share-based payments expenses 19 (522,104) (643,367) Occupancy expenses (134,873) (81,259) Research expenses 7 (3,023,384) (3,879,724) Total expenses (8,057,218) (10,217,863) Loss before income tax expense (4,928,074) (6,759,135) Income tax expense - - Loss after income tax expense for the year attributable to the owners of AnteoTech Ltd (4,928,074) (6,759,135) Other comprehensive income for the year, net of tax - - Total comprehensive income for the year attributable to the owners of AnteoTech Ltd (4,928,074) (6,759,135) Cents Cents Basic earnings per share 18 (0.17) (0.26) Diluted earnings per share 18 (0.17) (0.26)
Page 6
AnteoTech Ltd and its controlled entities Consolidated statement of financial position As at 30 June 2026 Consolidated Note 2026 2025 $ $ The above consolidated statement of financial position should be read in conjunction with the accompanying notes 3 Assets Current assets Cash and cash equivalents 8 5,700,745 2,340,306 Trade and other receivables 134,690 90,859 Other 9 5,710,034 295,797 Total current assets 11,545,469 2,726,962 Non-current assets Property, plant and equipment 10 1,020,855 1,398,870 Right-of-use assets 11 2,475,851 1,964,584 Other 9 356,471 356,471 Total non-current assets 3,853,177 3,719,925 Total assets 15,398,646 6,446,887 Liabilities Current liabilities Trade and other payables 12 505,120 438,853 Borrowings 5,209 4,768 Lease liabilities 13 558,353 545,569 Provisions 14 358,167 319,186 Total current liabilities 1,426,849 1,308,376 Non-current liabilities Borrowings 9,250 14,459 Lease liabilities 13 1,574,609 1,394,770 Provisions 14 589,400 579,077 Total non-current liabilities 2,173,259 1,988,306 Total liabilities 3,600,108 3,296,682 Net assets 11,798,538 3,150,205 Equity Contributed equity 15 116,831,193 103,776,890 Reserve 16 6,551,149 6,029,045 Accumulated losses (111,583,804) (106,655,730) Total equity 11,798,538 3,150,205
Page 7
AnteoTech Ltd and its controlled entities Consolidated statement of changes in equity For the year ended 30 June 2026 The above consolidated statement of changes in equity should be read in conjunction with the accompanying notes 4 Issued Accumulated Total equity capital Reserve losses Consolidated $ $ $ $ Balance at 1 July 2024 99,816,840 5,385,678 (99,896,595) 5,305,923 Loss after income tax expense for the year - - (6,759,135) (6,759,135) Other comprehensive income for the year, net of tax - - - - Total comprehensive income for the year - - (6,759,135) (6,759,135) Transactions with owners in their capacity as owners: Contributions of equity, net of transaction costs (note 15) 3,960,050 - - 3,960,050 Options expensed for the period (note 16) - 965,673 - 965,673 Options forfeited during the period (note 16) - (322,306) - (322,306) Balance at 30 June 2025 103,776,890 6,029,045 (106,655,730) 3,150,205 Issued Accumulated Total equity capital Reserve losses Consolidated $ $ $ $ Balance at 1 July 2025 103,776,890 6,029,045 (106,655,730) 3,150,205 Loss after income tax expense for the year - - (4,928,074) (4,928,074) Other comprehensive income for the year, net of tax - - - - Total comprehensive income for the year - - (4,928,074) (4,928,074) Transactions with owners in their capacity as owners: Contributions of equity, net of transaction costs (note 15) 13,054,303 - - 13,054,303 Options expensed for the period (note 16) - 544,059 - 544,059 Options forfeited during the period (note 16) - (21,955) - (21,955) Balance at 30 June 2026 116,831,193 6,551,149 (111,583,804) 11,798,538
Page 8
AnteoTech Ltd and its controlled entities Consolidated statement of cash flows For the year ended 30 June 2026 Consolidated Note 2026 2025 $ $ The above consolidated statement of cash flows should be read in conjunction with the accompanying notes 5 Cash flows from operating activities Receipts from customers (inclusive of GST) 410,019 1,122,555 Payments to suppliers and employees (inclusive of GST) (6,512,996) (9,328,973) (6,102,977) (8,206,418) Interest received 63,201 58,830 Other income 2,598,354 2,385,553 Interest and other finance costs paid (88,215) (64,154) Net cash used in operating activities (3,529,637) (5,826,189) Cash flows from investing activities Payments for term deposit (5,500,000) - Payments for property, plant and equipment 10 (54,934) (220,337) Proceeds from disposal of property, plant and equipment - 45,467 Net cash used in investing activities (5,554,934) (174,870) Cash flows from financing activities Proceeds from issue of shares 15 3,808,350 4,310,606 Principal repayment of leases (604,525) (639,436) Proceeds from exercise of options 15 10,032,004 35 Share issued transaction costs 15 (786,051) (350,591) Repayment of borrowings (4,768) (4,365) Net cash from financing activities 12,445,010 3,316,249 Net increase/(decrease) in cash and cash equivalents 3,360,439 (2,684,810) Cash and cash equivalents at the beginning of the financial year 2,340,306 5,025,116 Cash and cash equivalents at the end of the financial year 8 5,700,745 2,340,306
Page 9
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 6 Note 1. General information The financial statements cover AnteoTech Ltd as a Group consisting of AnteoTech Ltd (referred to hereafter as the 'Company' or 'parent entity') and the entities it controlled (collectively referred to hereafter as the 'Group' or 'AnteoTech') at the end of, or during, the year. The financial statements are presented in Australian dollars, which is AnteoTech Ltd's functional and presentation currency. AnteoTech Ltd is a listed public company limited by shares, incorporated and domiciled in Australia. Its registered office and principal place of business is: 4/26 Brandl Street, Eight Mile Plains QLD 4113 Rounding of amounts The Company is of a kind referred to in Corporations Instrument 2026/183, issued by the Australian Securities and Investments Commission, relating to ‘rounding off’. Amounts in this report have been rounded off in accordance with that Corporations Instrument to the nearest dollar. Note 2. Material accounting policy information The accounting policies adopted are consistent with those of the previous financial year, unless otherwise stated. Statement of compliance This preliminary final report (the Report) is to be read in conjunction with any public announcements made by AnteoTech Ltd during the reporting period in accordance with the continuous disclosure requirements of the Corporations Act 2001 and Australian Securities Exchange Listing Rules. The preliminary final report has been prepared in accordance with Australian Accounting Standards (AASBs) adopted by the Australian Accounting Standards Board and the Corporations Act 2001. Going concern The consolidated financial statements have been prepared on a going concern basis which contemplates the continuity of normal business activities and the realisation of assets and discharge of liabilities in the ordinary course of business. As at 30 June 2026, the Group has net assets of $11,798,538 (2025: $3,150,205) ;cash and cash equivalents of $5,700,745 (2025: $2,340,306) plus current term deposits of $5,500,000 (2025: $nil), and debt in the form of asset financing of $14,459 (2025: $19,227). The Company received additional funding in January and February 2026 through a $3,808,350 Share Placement (before costs). The shares issued under the Placement were priced at 1.55 cents per share with two attaching options per two shares acquired (one option was listed and the other option was unlisted . The listed options have expired as at 30 June 2026) . The exercise of all the Company’s 286,628,688 listed ADOO options at A$0.035, raised $10,032,004 (before costs) and materially strengthened the Company balance sheet. As the Group is currently loss making, the Group’s ability to continue to adopt the going concern assumption will depend upon a number of matters including the successful sales and/or commercialisation of the Group’s intellectual property and projects as well as successful capital injection in the future. The Directors acknowledge that whilst a requirement may exist for the Company to raise funds in the future, there will continue to be a material uncertainty that may cast significant doubt regarding the Group's ability to continue as a going concern and therefore, the Group may be unable to realise their assets and discharge their liabilities in the normal course of business. The Directors believe that the Group will be able to continue as a going concern, which contemplates continuity of normal business activities and the realisation of assets and the settlement of liabilities in the ordinary course of business and as a result the financial statements have been prepared on a going concern basis. Nevertheless, after taking into account the current financial position of the Group, the Group’s ability to raise further capital, the ability to control costs and the progress made on the commercialisation of its intellectual
Page 10
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 2. Material accounting policy information (continued) 7 property, the Directors have a reasonable expectation that the Group will have adequate resources to fund its future operational requirements and for these reasons they continue to adopt the going concern basis in preparing the financial report. Key activities supporting the Group’s ability to continue as a concern include: ● Several Advanced Battery Technologies commercial opportunities progressing through negotiation and product validation, including through: • a joint development terms agreement with Black Diamond Structures for a combined product using Anteo XTM (SiMRAX); • the sales and collaboration agreement with Xerabrid in relation to high-performance ceramic coated separators using Anteo S; • the evaluation of UltranodeTM for potential commercial scale use by Wyon AG; and • negotiations in relation to Joint Development Agreements with other battery manufacturers in relation to UltranodeTM 95. ● Business Development and potential sales growth from Life Sciences customers has focused on the high growth Indian market, Japan, South Korea, and increasingly the USA, and has identified a number of further opportunities where ongoing engagement is progressing positively with a number of prospective customers in relation to sales. ● Market entry opportunities into new jurisdictions and applications for AnteoTech are being executed as per the Strategic Review outcomes, prioritising sales of the Company’s market ready products and technologies and investing in the sales and marketing capability to successfully and expediently convert sales and grow revenues. ● A reduced cost base through Company restructuring with further cost initiatives has been implemented, with continuous improvement underway. ● The Group continues to explore opportunities to fund and co-fund development of customised solutions and grow with potential strategic partners. In the unlikely scenario where the Group is unable to continue as a going concern, it may be required to realise its assets and extinguish its liabilities other than in the ordinary course of business, and at amounts that differ from those stated in the consolidated financial statements. Note 3. Critical accounting judgements, estimates and assumptions The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts in the financial statements. Management continually evaluates its judgements and estimates in relation to assets, liabilities, contingent liabilities, revenue and expenses. Management bases its judgements, estimates and assumptions on historical experience and on other various factors, including expectations of future events, management believes to be reasonable under the circumstances. The resulting accounting judgements and estimates will seldom equal the related actual results. The judgements, estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities (refer to the respective notes) within the next financial year are discussed below. Share-based payment transactions The Group measures the cost of equity-settled share-based payment transactions with employees by reference to the fair value of the equity instruments at the date at which they are granted. The fair value is determined by using either the Monte Carlo or Black -Scholes model taking into account the terms and condi tions upon which the instruments were granted. The accounting estimates and assumptions relating to equity-settled share-based payments would have no impact on the carrying amounts of assets and liabilities within the next annual reporting period but may impact profit or loss and equity.
Page 11
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 3. Critical accounting judgements, estimates and assumptions (continued) 8 Lease term The lease term is a significant component in the measurement of both the right -of-use asset and lease liability. Judgement is exercised in determining whether there is reasonable certainty that an option to extend the lease or purchase the underlying asset will be exercised, or an option to terminate the lease will not be exercised, when ascertaining the periods to be included in the lease term. In determining the lease term, all facts and circumstances that create an economical incentive to exercise an ext ension option, or not to exercise a termination option, are considered at the lease commencement date. Factors considered may include the importance of the asset to the Group's operations; comparison of terms and conditions to prevailing market rates; incurrence of significant penalties; existence of significant leasehold improvements; and the costs and disruption to replace the asset. The Group reassesses whether it is reasonably certain to exercise an extension option, or not exercise a termination option, if there is a significant event or significant change in circumstances. Incremental borrowing rate Where the interest rate implicit in a lease cannot be readily determined, an incremental borrowing rate is estimated to discount future lease payments to measure the present value of the lease liability at the lease commencement date. Such a rate is based on what the Group estimates it would have to pay a third party to borrow the funds necessary to obtain an asset of a similar value to the right -of-use asset, with similar terms, security and economic environment. Lease make good provision A provision has been made for the present value of anticipated costs for future restoration of leased premises. The provision includes future cost estimates associated with closure of the premises. The calculation of this provision requires assumptions such as application of closure dates and cost estimates. The provision recognised for each site is periodically reviewed and updated based on the facts and circumstances available at the time. Changes to the estimated future costs for sites are recognised in the statement of financial position by adjusting the asset and the provision. Reductions in the provision that exceed the carrying amount of the asset will be recognised in profit or loss. Note 4. Operating segments Identification of reportable operating segments The Group has determined that it has only one operating segment. The operating segment identified is based on the internal reports that are reviewed and used by the Board of Directors (who are identified as the Chief Operating Decision Makers ('CODM')) in assessing performance and in determining the allocation of resources. While the Group's activities span the sales and marketing of its core chemical platform technology in two markets(Advanced Battery Technologies and Life Sciences) these applications and share common costs, including support personnel, premises, research infrastructure and corporate functions. Discrete financial information is not prepared or reviewed at a business for the purposes of assessing corporate performance or allocating resources. References to these businesses in the Directors' Report, Operating and Financial Review and market announcements reflect the nature of the Group's activities and are not indicative of separate financial reporting to the CODM. Management currently identifies the Group as having only one operating segment, being the development and commercialisation of AnteoTech's intellectual property and advanced chemicals and materials technologies. All significant operating decisions are based upon analysis of the Group as one segment. The financial results from the segment are equivalent to the consolidated financial statements of the Group as a whole. Major customers During the year ended 2026 approximately 59.0% (2025: 81.0%) of the Group's external revenue was derived from sales to one customer. Accounting policy for operating segments Operating segments are presented using the 'management approach', where the information presented is on the same basis as the internal reports provided to the Chief Operating Decision Makers ('CODM'). The CODM is responsible for the allocation of resources to operating segments and assessing their performance.
Page 12
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 9 Note 5. Revenue from contracts with customers Consolidated 2026 2025 $ $ Product sales 402,994 885,415 Licence fees and royalties - 30,963 Contract services 64,595 52,500 Revenue from contracts with customers 467,589 968,878 Note 6. Other income Consolidated 2026 2025 $ $ Profit on disposal of property, plant and equipment - 45,467 R&D tax concession 2,588,632 2,385,553 Other 9,722 - Other income 2,598,354 2,431,020
Page 13
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 10 Note 7. Expenses Consolidated 2026 2025 $ $ Loss before income tax includes the following specific expenses: Depreciation Plant and equipment 210,801 212,353 Fixtures, fittings and office equipment 221,675 224,059 Land and buildings right-of-use assets 692,331 686,970 Total depreciation 1,124,807 1,123,382 Employee benefits expenses - total Salaries and fees 2,950,918 4,314,497 Superannuation contributions 320,554 409,170 Share-based payments 522,104 643,367 3,793,576 5,367,034 Administrative expenses Staff related expenses 1,402,184 1,941,836 Directors' fees 207,795 335,000 Professional services 336,906 671,523 Other administrative costs 608,559 901,275 2,555,444 3,849,634 Research expenses Staff related expenses 2,233,191 2,818,564 Lab and material equipment 417,764 624,487 Consulting 372,429 436,673 3,023,384 3,879,724 Finance costs Interest and finance charges paid/payable on lease liabilities 88,215 64,154 Leases Short-term lease payments 2,388 1,722 Note 8. Cash and cash equivalents Consolidated 2026 2025 $ $ Current assets Cash on hand 2,564 2,691 Cash at bank* 5,698,181 2,337,615 5,700,745 2,340,306 * Excluding the $5,500,000 6-month Term Deposit maturing on 18 December 2026 and detailed in note 9.
Page 14
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 11 Note 9. Other Consolidated 2026 2025 $ $ Current assets Prepayments 210,034 295,797 Term deposit 5,500,000 - 5,710,034 295,797 Non-current assets Term deposit 30,000 30,000 Bank guarantees 326,471 326,471 356,471 356,471 6,066,505 652,268 Term deposit Term deposits with original maturities exceeding three months are classified as other financial assets. As at 30 June 2026, this includes a $5,500,000 6-month term deposit maturing on 18 December 2026. Note 10. Property, plant and equipment Consolidated 2026 2025 $ $ Non-current assets Plant and equipment - at cost 2,424,266 2,522,280 Less: Accumulated depreciation (1,935,493) (1,847,108) 488,773 675,172 Fixtures, fittings and office equipment - at cost 1,362,389 1,682,977 Less: Accumulated depreciation (830,307) (959,279) 532,082 723,698 1,020,855 1,398,870
Page 15
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 10. Property, plant and equipment (continued) 12 Reconciliations Reconciliations of the written down values at the beginning and end of the current and previous financial year are set out below: Fixtures, fittings and Plant and equipment office equipment Total Consolidated $ $ $ Balance at 1 July 2024 675,817 939,142 1,614,959 Additions 211,708 8,878 220,586 Disposals - (263) (263) Depreciation expense (212,353) (224,059) (436,412) Balance at 30 June 2025 675,172 723,698 1,398,870 Additions 24,402 30,532 54,934 Disposals - (473) (473) Depreciation expense (210,801) (221,675) (432,476) Balance at 30 June 2026 488,773 532,082 1,020,855 Comparatives Comparative information has been restated to reclassify assets with a net book value of $3,761 from property, plant and equipment to right-of-use assets to correct the prior year presentation. Note 11. Right-of-use assets Consolidated 2026 2025 $ $ Non-current assets Land and buildings - right-of-use 3,805,314 4,346,949 Less: Accumulated depreciation (1,329,463) (2,382,365) 2,475,851 1,964,584 The Group leases office space. Rental contracts are typically made for fixed periods of 1 to 5 years but may have extension options. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. The Group leases office equipment under agreements of various terms. Leases that are low -value or less than 12 months are expensed as incurred and not capitalised as right-of-use assets Comparatives Comparative information has been restated to reclassify assets with a net book value of $3,761 from property, plant and equipment to right-of-use assets to correct the prior year presentation.
Page 16
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 11. Right-of-use assets (continued) 13 Reconciliations Reconciliations of the written down values at the beginning and end of the current and previous financial year are set out below: Land and buildings Consolidated $ Balance at 1 July 2024 2,282,395 Lease make good provision 100,000 Lease adjustments/modifications 269,159 Depreciation expense (686,970) Balance at 30 June 2025 1,964,584 Lease make good provision 406,450 Lease modification 797,148 Depreciation expense (692,331) Balance at 30 June 2026 2,475,851 The lease modification is a result of the extension of the lease for 26 Brandl Street through to 30 November 2029. Note 12. Trade and other payables Consolidated 2026 2025 $ $ Current liabilities Trade payables 254,715 262,375 Sundry creditors and accrued expenses 250,405 176,478 505,120 438,853 The amounts are unsecured and are usually paid within 14 to 30 days of recognition. Note 13. Lease liabilities Consolidated 2026 2025 $ $ Current liabilities Lease liability 558,353 545,569 Non-current liabilities Lease liability 1,574,609 1,394,770 2,132,962 1,940,339
Page 17
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 14 Note 14. Provisions Consolidated 2026 2025 $ $ Current liabilities Annual leave 231,820 202,944 Long service leave 126,347 116,242 358,167 319,186 Non-current liabilities Long service leave 61,357 31,497 Lease make good 528,043 547,580 589,400 579,077 947,567 898,263 Lease make good The provision represents the present value of the estimated costs to make good the premises leased by the Group at the end of the respective lease terms. Movements in lease make good provision Movements in the lease make good provision during the current financial year are set out below: Consolidated 2026 2025 $ $ Carrying amount at the start of the year 547,580 551,833 Recognition of make good provision 406,450 100,000 Derecognition of make good provision through profit or loss (447,580) - Fair value remeasurement - (178,000) Interest 21,593 73,747 528,043 547,580 Note 15. Contributed equity Consolidated 2026 2025 2026 2025 Shares Shares $ $ Ordinary shares - fully paid 3,259,767,301 2,705,300,325 116,831,193 103,776,890
Page 18
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 15. Contributed equity (continued) 15 Movements in ordinary share capital Details Date Shares Issue price $ Balance 1 July 2024 2,468,287,352 99,816,840 Shares issued - exercise of options 31 July 2024 352,200 $0.0001 35 Shares issued - employee incentives 13 September 2024 21,130,463 $0.0000 - Shares issued - placement 20 November 2024 175,000,000 $0.0200 3,500,000 Shares issued - entitlement offer 16 December 2024 40,530,310 $0.0200 810,606 Share issue costs (350,591) Balance 30 June 2025 2,705,300,325 103,776,890 Shares issued - employee incentives 28 August 2025 22,138,295 $0.0000 - Shares issued - placement 5 February 2026 245,699,993 $0.0155 3,808,350 Shares issued - exercise of options 2 June 2026 118,326,435 $0.0350 4,141,425 Shares issued - exercise of options 5 June 2026 168,302,253 $0.0350 5,890,579 Share issue costs (786,051) Balance 30 June 2026 3,259,767,301 116,831,193 Note 16. Reserve Consolidated 2026 2025 $ $ Share-based payments reserve 6,551,149 6,029,045 Refer to note 19 for further details. Share-based payments reserve The reserve is used to recognise the value of equity benefits provided to employees and Directors as part of their remuneration, and other parties as part of their compensation for services. Movements in reserves Movements in each class of reserve during the current and previous financial year are set out below: Share-based payments reserve Consolidated $ Balance at 1 July 2024 5,385,678 Options expense 965,673 Options lapsed (322,306) Balance at 30 June 2025 6,029,045 Options expense 544,059 Options lapsed (21,955) Balance at 30 June 2026 6,551,149
Page 19
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 16 Note 17. Contingent liabilities The Group has provided bank guarantees totalling $326,471 in favour of the lessor as security for its obligations under its lease agreements. No amounts have been recognised as liabilities in relation to these guarantees, as no claims have been made against them at the reporting date. Note 18. Earnings per share Consolidated 2026 2025 $ $ Loss after income tax attributable to the owners of AnteoTech Ltd (4,928,074) (6,759,135) Number Number Weighted average number of ordinary shares used in calculating basic earnings per share 2,842,071,596 2,613,600,684 Weighted average number of ordinary shares used in calculating diluted earnings per share 2,842,071,596 2,613,600,684 Cents Cents Basic earnings per share (0.17) (0.26) Diluted earnings per share (0.17) (0.26) Options are considered to be potential ordinary shares. For the years ended 30 June 2026 and 30 June 2025 their conversion to ordinary shares would have had the effect of reducing the loss per share and therefore considered to be anti-dilutive. Accordingly, the options were not included in the determination of diluted earnings per share. There were 297,958,151 unlisted options on issue as at 30 June 2026 which have not been considered for loss per share calculations (2025: 148,422,458 listed and 153,888,483 unlisted options). The unlisted options not associated with share-based options outstanding at the end of 2026 and their movement during the year were as follows: 2026 Balance at Balance at Exercise the start of Forfeited the end of Grant date Expiry date price the year Granted Expired the year 13/09/2023 13/09/2026 $0.0640 71,376,921 - - - 71,376,921 14/11/2023 13/09/2026 $0.0640 1,875,000 - - - 1,875,000 01/09/2023 30/11/2026 $0.0640 5,000,000 - - - 5,000,000 04/02/2026 31/01/2028 $0.0350 - 138,206,230 - - 138,206,230 78,251,921 138,206,230 - - 216,458,151 The 71,376,921 and 138,206,230 options relate to the attaching options issued as part of the issue of ordinary shares under the placement and share purchase plan during the current and previous periods. For the options granted on 4 February 2026, o ne attaching unlisted option was issued for every two ordinary shares acquired. One attaching listed option was also issued for every two ordinary shares acquired; however, this section is for unlisted options only . These do not form part of any remuneration and thereby not subject to AASB 2 Share based payments. The unlisted options outstanding at the end of 2025 and their movement during the year were as follows:
Page 20
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 18. Earnings per share (continued) 17 (24,425,625) 2025 Balance at Expired Balance at Exercise the start of the end of Grant date Expiry date price the year Granted Forfeited the year 13/09/2023 13/09/2026 $0.0640 71,376,921 - - - 71,376,921 14/11/2023 13/09/2026 $0.0640 1,875,000 - - - 1,875,000 01/09/2023 30/11/2026 $0.0640 5,000,000 - - - 5,000,000 78,251,921 - - - 78,251,921 The 71,376,921 options relate to the attaching options issued as part of the issue of ordinary shares under the placement and share purchase plan during the previous period. One attaching option was issued for every two ordinary shares acquired. These do not form part of any remuneration and thereby not subject to AASB 2 Share based payments. Note 19. Share-based payments The Group has an Employee Share Option Scheme for Directors, senior executives, employees and key consultants of the Group whereby those parties may be granted options to purchase ordinary shares in the Company. There were 30,500,000 (2025: 20,100,000) options issued under the Equity Incentive Plan during the year (excluding 42,500,000 Director options granted post the Annual General Meeting). 118,326,435 shares were issued on 2 June 2026 from option exercises; and 168,302,253 shares were issued on 5 June 2026 from option exercises; and other than these two tranches, no other options were exercised during the year (2025: 352,200) (issued in prior periods) with 24,425,625 (2025: 61,488,253) options lapsing. Set out below are summaries of options granted under the plan: The unlisted options outstanding at the end of 2026 and their movement during the year were as follows: 2026 Balance at Balance at Exercise the start of Forfeited the end of Grant date Expiry date price the year Granted Expired the year 11/10/2022 31/07/2025 $0.0001 1,254,687 - (1,050,625) (204,062) - 17/11/2022 04/10/2026 $0.1125 20,000,000 - - (20,000,000) - 16/12/2022 31/07/2025 $0.0001 431,875 - - (431,875) - 14/11/2023 30/11/2026 $0.0480 33,750,000 - (3,750,000) (19,500,000) 10,500,000 15/10/2024 26/11/2027 $0.0480 17,700,000 - (10,725,000) (2,575,000) 4,400,000 01/01/2025 26/11/2027 $0.0480 2,500,000 - - - 2,500,000 19/08/2025 19/08/2029 $0.0375 - 30,000,000 - - 30,000,000 24/10/2025 19/08/2029 $0.0375 - 24,800,000 (8,900,000) - 15,900,000 26/11/2025 26/11/2028 $0.0375 - 12,500,000 - - 12,500,000 24/06/2026 19/08/2029 $0.0375 - 5,700,000 - - 5,700,000 75,636,562 73,000,000 (42,710,937) 81,500,000 The unlisted options outstanding at the end of 2025 and their movement during the year were as follows:
Page 21
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 19. Share-based payments (continued) 18 2025 Balance at Expired/ Balance at Exercise the start of forfeited/ the end of Grant date Expiry date price the year Granted Exercised other the year 02/08/2021 30/06/2025 $0.0001 352,200 - (352,200) - - 02/08/2021 31/07/2025 $0.0001 235,600 - - (235,600) - 01/12/2021 31/07/2025 $0.0001 - - - - - 11/10/2022 31/07/2025 $0.0001 2,007,500 - - (752,813) 1,254,687 11/10/2022 31/12/2025 $0.0001 3,041,160 - - (3,041,160) - 17/11/2022 21/04/2025 $0.1603 7,000,000 - - (7,000,000) - 17/11/2022 21/04/2025 $0.1603 13,500,000 - - (13,500,000) - 17/11/2022 04/10/2026 $0.1125 30,000,000 - - (10,000,000) 20,000,000 16/12/2022 31/12/2025 $0.0001 38,355 - - (38,355) - 16/12/2022 31/07/2025 $0.0001 2,902,200 - - (2,470,325) 431,875 14/11/2023 30/11/2026 $0.0480 44,500,000 - - (10,750,000) 33,750,000 15/10/2024 26/11/2027 $0.0480 - 20,600,000 - (2,900,000) 17,700,000 26/11/2024 26/11/2027 $0.0480 - 10,800,000 - (10,800,000) - 01/01/2025 26/11/2027 $0.0480 - 2,500,000 - - 2,500,000 103,577,015 33,900,000 (352,200) (61,488,253) 75,636,562 Weighted average exercise price $0.0001 The 10,800,000 options issued relate to those options approved at the annual general meeting in November 2024 to be issued to the previous the Managing Director and Chief Executive Officer. The options have lapsed due to the resignation of the previous Managing Director and Chief Executive Officer prior to vesting. The number of options vested and exercisable at the end of each reporting period were as follows: Consolidated 2026 2025 Number Number Options vested and exercisable 230,408,151 106,813,483 Options not yet vested 67,550,000 47,075,000 Total options outstanding 297,958,151 153,888,483 Options not yet vested at 30 June 2026 are subject to the following vesting conditions: The option tranche granted 15 October 2024 has 2,200,000 options which vest on 26 November 2026. The options will be forfeited if the holder ceases employment prior to the vesting date, unless the Board determines otherwise. The option tranche granted 1 January 2025 has 1,250,000 options which vest on 26 November 2026. The options will be forfeited if the holder ceases employment prior to the vesting date, unless the Board determines otherwise. The option tranche granted 19 August 2025 has 30,000,000 options which vest based on the conditions outlined in the section below titled “Valuation model - 2026 unlisted MD/CEO options” The option tranche granted 24 October 2025 has 15,900,000 options which vest based on the conditions outlined in the section below titled “Valuation model - 2026 unlisted senior staff options”. The option t ranche granted 26 November 2025 has 12,500,000 options which vest based on the conditions outlined in the section below titled “Valuation model - 2026 unlisted Non-Executive Director Options”.
Page 22
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 19. Share-based payments (continued) 19 The option tranche granted 26 June 2026 has 5,700,000 options which vest based on the conditions outlined in the section below titled “Valuation model - 2026 unlisted senior staff options”. The number of unlisted options issued to Directors, staff or third parties in relation to services rendered during the current and previous year are summarised below: Consolidated 2026 2025 Number Number Directors Options 12,500,000 - CEO Options 30,000,000 10,800,000 Staff Options 30,500,000 20,100,000 Third-Party Options - 3,000,000 73,000,000 33,900,000 The number of performance rights issued to Directors, staff or third parties in relation to services rendered during the current and previous year are summarised below: Consolidated 2026 2025 Number Number Balance at the start of the year - 2,820,000 Converted to ordinary shares - (2,820,000) Granted - 5,400,000 Lapsed - (5,400,000) Balance at end of the year - - The fair value of the options granted during the year ended 30 June 2026 were all determined by the Company using a Monte Carlo pricing model that takes into account the share price at grant date, exercise price, expected volatility of 90% (determined by reference to historical volatility of the share price of similar companies), price hurdles, option life and risk-free rate. Valuation model - 2026 unlisted Non-Executive Director Options (approved at the annual general meeting) Number Share price at Exercise Risk-free Hurdle Fair value at grant date Grant date Expiry date issued grant date price rate price per option $ $ % $ $ 26/11/2025 26/11/2028 6,250,000 $0.0190 $0.0375 3.75% $0.0375 $0.0082 26/11/2025 26/11/2028 6,250,000 $0.0190 $0.0375 3.75% $0.0500 $0.0081 12,500,000
Page 23
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 19. Share-based payments (continued) 20 The options will vest as follows: Vesting condition Vesting condition No. of Share Price Hurdle Service Period Condition options (being the 60-trading day VWAP of Shares – to be achieved on or before the date the options expire) (during which the Directors must remain continuously employed by the Company) 6,250,000 $0.0375 12 months from commencement date 6,250,000 $0.0500 24 months from commencement date Valuation model - 2026 unlisted MD/CEO options (approved at the annual general meeting) Number Share price at Exercise Risk-free Hurdle Fair value at grant date Grant date Expiry date issued grant date price rate price1 per option $ $ % $ $ 26/11/2025 19/08/2029 10,000,000 $0.0190 $0.0375 3.75% $0.0375 $0.0090 26/11/2025 19/08/2029 10,000,000 $0.0190 $0.0375 3.75% $0.0500 $0.0087 26/11/2025 19/08/2029 10,000,000 $0.0190 $0.0375 3.75% $0.0625 $0.0088 30,000,000 1 Being the 60-trading average of shares – to be achieved on or before expiry date. The options issued to the CEO were approved by shareholders at the AGM on 26 November 2025. The options are subject to service conditions and will be dependent on the employee remaining in employment as at vesting date. The fair value was re- estimated on the AGM date (26/11/2025) after initially measuring at service commencement date of 19/8/2025. The options will vest as follows: Vesting condition Vesting condition No. of Share Price Hurdle Service Period Condition options (being the 60-trading day VWAP of Shares – to be achieved on or before the date the options expire) (during which the MD & CEO must remain continuously employed by the Company) 10,000,000 $0.0375 12 months from commencement date 10,000,000 $0.0500 24 months from commencement date 10,000,000 $0.0625 36 months from commencement date Valuation model - 2026 unlisted senior staff options Number Share price at Exercise Risk-free Hurdle Fair value at grant date Grant date Expiry date issued grant date price rate price1 per option $ $ % $ $ 14/10/2025 19/08/2029 12,400,000 $0.0220 $0.0375 3.75% $0.0375 $0.0090 14/10/2025 19/08/2029 12,400,000 $0.0220 $0.0375 3.75% $0.0500 $0.0087 24/06/2026 19/08/2029 2,850,000 $0.0280 $0.0375 4.35% $0.0375 $0.0179 24/06/2026 19/08/2029 2,850,000 $0.0280 $0.0375 4.35% $0.0500 $0.0178 30,500,000 1 Being the 60-trading average of shares – to be achieved on or before expiry date.
Page 24
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 19. Share-based payments (continued) 21 The 24,800,000 options issued to senior staff were approved by the Board on 14 October 2025. The options are subject to service conditions and will be dependent on the employees remaining in employment as at the vesting date. The fair value of the options were determined by the Company using a Monte Carlo pricing model that takes into account the share price at grant date, exercise price, expected volatility of 90% (determined by reference to historical volatility of the share price of similar companies), price hurdles, option life and risk -free rate. The 5,700,000 options issued to senior staff with a Grant Date of 24 June 2026. The options are subject to both service and share price performance conditions and will vest only if the applicable vesting conditions are satisfied, including the employee remaining in employment at the vesting date. The fair value of the options were determined by the Company using a Monte Carlo pricing model that takes into account the share price at grant date, exercise price, expected volatility of 111% (determined by reference to historical volatility of the share price of AnteoTech shares), price hurdles, option life and risk-free rate. Vesting condition Vesting condition No. of Share Price Hurdle Service Period Condition options (being the 60-trading day VWAP of Shares – to be achieved on or before the date the options expire) (during which the employee must remain continuously employed by the Company) 12,400,000 $0.0375 12 months from commencement date 12,400,000 $0.0500 24 months from commencement date 2,850,000 $0.0375 12 months from commencement date 2,850,000 $0.0500 24 months from commencement date Consolidated 2026 2025 $ $ Allocation of value of options issued to staff during 2022 - 554 Allocation of value of options issued to CEO during 20231 - 88,488 Allocation of value of options issued to staff during 2023 95 3,340 Allocation of value of options issued to CEO during 20242 - 47,231 Allocation of value of options issued to Directors during 20243 4,484 38,350 Allocation of value of performance rights issued to CEO during 20244 - 16,222 Allocation of value of options issued to staff during 20245 25,058 206,112 Allocation of value of options issued to third parties during 20246 - 10,616 Allocation of value of options issued to CEO during 20257 - 18,723 Allocation of value of performance rights issued to CEO during 20258 - 21,830 Allocation of value of options issued to staff during 20259 26,657 193,018 Allocation of value of options issued to third parties during 202510 - 5,200 Allocation of value of options issued to Directors during 202611 45,308 - Allocation of value of options issued to CEO during 202612 140,504 - Allocation of value of options issued to staff during 202613 78,695 - Allocation of value of equity settled incentives to be issued to staff14 223,257 315,989 Adjustment for forfeited options (21,955) (322,306) Total share-based payments expenses 522,104 643,367
Page 25
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 19. Share-based payments (continued) 22 1 Options issued to the CEO during 2023 were approved by shareholders at the AGM on 17 November 2022, being the grant date. 2 10,000,000 long-term incentive options were granted to the CEO and approved at the AGM on the 14 November 2023. 3 7,000,000 long-term incentive options were granted to Directors and approved at the AGM on the 14 November 2023. 4 Up to 2,820,000 performance awards were granted to the CEO and approved at the AGM on the 14 November 2023 as part of a short-term incentive award. 5 27,500,000 long-term incentive options were granted to senior staff under the Company’s Equity Incentive Plan. 6 5,000,000 long-term options were issued to third parties in relation to ongoing advisory services. 7 10,800,000 long-term incentive options were granted to the CEO and approved at the AGM on the 26 November 2024. 8 Up to 5,400,000 performance awards were granted to the CEO and approved at the AGM on the 26 November 2024 as part of a short-term incentive award. 9 17,600,000 long-term incentive options were granted to senior staff under the Company’s Equity Incentive Plan. 10 3,000,000 long-term options were issued to third parties in relation to ongoing executive services. 11 Up to 12,500,000 long-term options were granted to the Directors and approved at the AGM on the 26 November 2025 as part of a long-term incentive award. 12 Up to 30,000,000 long-term options were granted to the CEO and approved at the AGM on the 26 November 2025 as part of a long-term incentive award. 13 Up to 30,500,000 long-term options were granted to staff as part of a long-term incentive award. 14 Employees of the Company are entitled to participate in the Company’s short-term incentive (STI) plan. The STI will be settled by the issue of ordinary shares and determined following a review of the non- market performance conditions over the vesting period.
Page 26
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 23 The shareholder information set out below was applicable as at 21 August 2026. Distribution of equitable securities Analysis of number of equitable security holders by size of holding: Ordinary shares % of total Number shares of holders issued 1 to 1,000 244 2.74 1,001 to 5,000 2,105 23.65 5,001 to 10,000 998 11.21 10,001 to 100,000 3,280 36.85 100,001 and over 2,273 25.54 8,900 100.00 Holding less than a marketable parcel 4,779 53.70 Equity security holders Twenty largest quoted equity security holders The names of the twenty largest security holders of quoted equity securities are listed below: Ordinary shares % of total shares Number held issued MARCOLONGO NOMINEES PTY LTD 99,024,869 3.04 FIRST CAPE MANAGEMENT PTY LTD 55,195,509 1.69 CITICORP NOMINEES PTY LIMITED 52,095,735 1.60 AWO & CAO INVESTMENTS PTY LTD 48,900,000 1.50 ADDISON LAKE QUALITY HIRE PTY LIMITED 38,844,879 1.19 MR PETER FREDERICK KEMMIS 36,216,676 1.11 BNP PARIBAS NOMINEES PTY LTD 34,418,226 1.06 FOSSIL SUPER PTY LTD 33,920,000 1.04 MR CLAUS KURT DZALAKOWSKI 30,000,000 0.92 BOND STREET CUSTODIANS LIMITED 25,100,000 0.77 BOND STREET CUSTODIANS LIMITED 24,852,749 0.76 MCRAE SUPERANNUATION PTY LTD 24,000,000 0.74 TERRY & LINDEN DEAVIN SUPER PTY LTD 23,500,212 0.72 MR CLAUS KURT DZALAKOWSKI & MRS MICHELLE GAY DZALAKOWSKI 23,000,000 0.71 COMPUTER VISIONS PTY LTD 22,132,994 0.68 MR ANTONIO DI LALLA 21,986,924 0.67 MR GARETH EDWARD GRANT 21,241,009 0.65 MR ROBERT COSIMO MACRI 20,305,134 0.62 MR PHILIP MICHAEL DEAVIN & MRS CHIMENE MAREE DEAVIN 19,162,769 0.59 MR ANTHONY WILLIAM OLDING & MRS CAROLINE ANNE OLDING 18,100,000 0.56 671,997,685 20.61 Shareholder Information
Page 27
AnteoTech Ltd and its controlled entities Notes to the consolidated financial statements 30 June 2026 Note 19. Share-based payments (continued) 24 Unquoted equity securities Employee Option Plan The Employee Option Plan last approved by shareholders on 26 November 2024, provides that employees may be issued options to acquire shares in the Company. These options are not quoted on the Australian Stock Exchange. As at the date of this report, the total number of Options on issue under the Employee Option Plan was 81,500,000. (a) Other Unlisted Options The following unlisted options to acquire ordinary shares are on issue as at 21 August 2026: Number on issue Options over ordinary shares issued to directors 5,000,000 Options over ordinary shares issued to other parties 211,458,151 Total unlisted options to acquire ordinary shares 216,458,151 Voting rights The voting rights attached to ordinary shares are set out below: Ordinary shares (a) o n a show of hands every member present at a meeting in person or by proxy, attorney or representative will shall have one vote; and (b) on a poll every member present at a meeting in person or by proxy, attorney or representative will have one vote for each fully paid share held. There are no other classes of quoted equity securities. Shareholder Information